CD74 and cancer: Applied to LUAD and LUSC datasets, our approach successfully identified a stable core set of pathogenic genes, including both highly expressed genes (e.g., CD74, HGF) and stably expressed genes (e.g., BRAF, KDM6A), which play critical roles in cancer progression.